BUPROPION HYDROCHLORIDE
- Product NDC
- 70518-2772
- 11-digit product format
- 705182772
- Labeler code
- 70518
- Product ID
- 70518-2772_ea377fc4-90aa-de89-e053-2a95a90a4dfd
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- BUPROPION HYDROCHLORIDE
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA210497
- Marketing category
- ANDA
- Marketing start
- 2020-06-08
- Marketing end
- 0000-00-00
- Substance
- BUPROPION HYDROCHLORIDE
- Active strength
- 300 mg/1
- Pharmacologic classes
- Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70518-2772 | BUPROPION HYDROCHLORIDE TABLET, EXTENDED RELEASE [REMEDYREPACK INC.] | 11 | Legacy NDC | 20250403_e187f83e-ee5e-46d9-9b4f-7e818d16776d.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-2772-0 | 70518277200 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70518-2772-0) | 2020-06-08 | 0000-00-00 | No | No | Current |
| 70518-2772-1 | 70518277201 | 30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (70518-2772-1) | 2020-11-05 | 0000-00-00 | No | No | Current |
| 70518-2772-2 | 70518277202 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70518-2772-2) | 2021-02-26 | 0000-00-00 | No | No | Current |
| 70518-2772-3 | 70518277203 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70518-2772-3) | 2021-07-09 | 0000-00-00 | No | No | Current |